Insufficient scRNA-seq data for expression of RLN2 at single-cell level.
Insufficient scRNA-seq data for expression of RLN2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 92% | 102.43 | 226 / 245 | 84% | 26.58 | 422 / 502 |
thymus | 84% | 9.57 | 551 / 653 | 76% | 1.81 | 457 / 605 |
breast | 83% | 20.19 | 379 / 459 | 77% | 9.52 | 856 / 1118 |
kidney | 96% | 20.74 | 85 / 89 | 51% | 1.44 | 459 / 901 |
lung | 81% | 13.19 | 469 / 578 | 35% | 0.88 | 405 / 1155 |
pancreas | 80% | 7.81 | 263 / 328 | 33% | 0.64 | 58 / 178 |
ovary | 34% | 2.89 | 62 / 180 | 74% | 3.42 | 319 / 430 |
intestine | 52% | 6.14 | 500 / 966 | 49% | 1.36 | 260 / 527 |
stomach | 56% | 3.86 | 200 / 359 | 44% | 1.53 | 127 / 286 |
spleen | 100% | 23.35 | 240 / 241 | 0% | 0 | 0 / 0 |
bladder | 43% | 2.95 | 9 / 21 | 49% | 1.81 | 246 / 504 |
uterus | 57% | 6.28 | 97 / 170 | 31% | 0.85 | 140 / 459 |
esophagus | 47% | 3.87 | 679 / 1445 | 32% | 0.74 | 59 / 183 |
lymph node | 0% | 0 | 0 / 0 | 76% | 2.96 | 22 / 29 |
brain | 68% | 6.55 | 1796 / 2642 | 8% | 0.14 | 55 / 705 |
skin | 56% | 5.46 | 1021 / 1809 | 14% | 0.44 | 65 / 472 |
heart | 67% | 6.05 | 573 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 59% | 23.81 | 544 / 929 | 0% | 0 | 0 / 0 |
adipose | 51% | 3.60 | 618 / 1204 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 27% | 0.70 | 12 / 45 |
blood vessel | 23% | 1.37 | 307 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 18% | 0.34 | 14 / 80 |
muscle | 14% | 0.69 | 116 / 803 | 0% | 0 | 0 / 0 |
liver | 8% | 0.42 | 18 / 226 | 4% | 0.09 | 17 / 406 |
adrenal gland | 10% | 0.50 | 25 / 258 | 2% | 0.04 | 5 / 230 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007165 | Biological process | signal transduction |
GO_0010628 | Biological process | positive regulation of gene expression |
GO_0007565 | Biological process | female pregnancy |
GO_0045766 | Biological process | positive regulation of angiogenesis |
GO_0050790 | Biological process | regulation of catalytic activity |
GO_0005576 | Cellular component | extracellular region |
GO_0005179 | Molecular function | hormone activity |
Gene name | RLN2 |
Protein name | Relaxin 2 Prorelaxin H2 [Cleaved into: Relaxin B chain; Relaxin A chain] |
Synonyms | |
Description | FUNCTION: Relaxin is an ovarian hormone that acts with estrogen to produce dilatation of the birth canal in many mammals. May be involved in remodeling of connective tissues during pregnancy, promoting growth of pubic ligaments and ripening of the cervix. |
Accessions | ENST00000416837.1 P04090 ENST00000381627.4 [P04090-1] H0Y5M9 |